tiprankstipranks
Trending News
More News >
Solvonis Therapeutics plc (GB:SVNS)
LSE:SVNS

Solvonis Therapeutics (SVNS) Revenue

Compare
12 Followers

Solvonis Therapeutics Revenue

Solvonis Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Increased -100.00%. In the fiscal year ending Dec 31, 2024, Solvonis Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
£0
Employees
3
Market Cap
£20.42M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
-587.00K
Dec 31, 2023
587.00K45.00K+108.30%
Dec 31, 2022
542.00K323.00K+247.49%
Dec 31, 2021
219.00K-471.86K+31.70%
Dec 31, 2020
690.86K360.86K+209.35%
Dec 31, 2019
330.00K301.00K+1,137.97%
Dec 31, 2018
29.00K